InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Thursday, 09/08/2022 5:17:44 PM

Thursday, September 08, 2022 5:17:44 PM

Post# of 43
This seems to be the possibly Best developement in the entire psychedelic sector, IMO. A Golden Ticket?
...GLTA...


"The Company has now completed its intravenous formulation (“IVF”) that will be used in the Phase 1 DMT study. The formulation was developed by the Centre for Human Drug Research (“CHDR”) and its affiliated pharmacy at the Leiden University Medical Center in the Netherlands. The Company has applied for ethics and clinical trial approval and is expecting to have a response shortly."

https://www.globenewswire.com/news-release/2022/09/08/2512310/0/en/Algernon-Pharmaceuticals-Secures-Lead-Sponsorship-of-2022-Wonderland-Psychedelic-Conference-in-Miami.html